Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis

Journal of Vascular Research

Volumn 46, Issue 5, 2009, Pages 495-502

  Shapiro, Nathan I ^a   Yano, Kiichiro ^a   Sorasaki, Midori ^a   Fischer, Chris ^a   Shih, Shou Ching ^a   Aird, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

End organ damage; Endothelial dysfunction; Endotoxemia; Sepsis; Skin biopsy

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; IMMUNOHISTOCHEMISTRY; LIGATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SKIN BIOPSY;

ANIMALS; BIOLOGICAL MARKERS; BIOPSY; CECUM; DERMIS; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIAL CELLS; INTERCELLULAR ADHESION MOLECULE-1; LIGATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; P-SELECTIN; RNA, MESSENGER; SEPSIS; SERPINS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1; WOUNDS, STAB;

EID: 63549117319     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210662     Document Type: Article

References (29)

1. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765-3777.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29: 1303-1310.
3. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123.
4. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
5. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
6. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW: Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31: 670-675.
7. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-658.
8. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time. Crit Care Med 1998;26:2078-2086.
9. Matsuda N, Hattori Y, Jesmin S, Gando S: Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Mol Pharmacol 2005;67:1018-1025.
10. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S: Changes of the hemostatic network in critically ill patients - is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000;28:445-450.
11. Sessler CN: Steroids for septic shock: back from the dead? (Con). Chest 2003;123:482S-489S.
12. Krafte-Jacobs B, Brilli R: Increased circulating thrombomodulin in children with septic shock. Crit Care Med 1998;26:933-938.
13. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC: A prospective, observational study of soluble Flt-1 and vascular endothelial growth factor in sepsis. Shock 2008;29:452-457.
14. Aird WC: Endothelial Cell Heterogeneity. Stuttgart, Schattauer Verlag, 1997.
15. Aird WC: Spatial and temporal dynamics of the endothelium. J Thromb Haemost 2005;3: 1392-1406.
16. Aird WC: Phenotypic heterogeneity of the endothelium. II. Representative vascular beds. Circ Res 2007;100:174-190.
17. Aird WC: Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ Res 2007;100:158-173.
18. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC: Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203:1447-1458.
19. Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H: Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005;116:91-100.
20. Briassoulis G, Papassotiriou I, Mavrikiou M, Lazaropoulou C, Margeli A: Longitudinal course and clinical significance of TGFbeta1, sL- and sE-selectins and sICAM-1 levels during severe acute stress in children. Clin Biochem 2007;40:299-304.
21. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345: 408-416.
22. Leone M, Boutiere B, Camoin-Jau L, Albanese J, Horschowsky N, Mege JL, Martin C, Dignat-George F: Systemic endothelial activation is greater in septic than in traumatichemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002;30:808-814.
23. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, Wyllie S, Louwrier K, Fox SB, Gatter KC, Day NP, Tran TH, White NJ, Berendt AR: Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 1998;152:1477-1487.
24. Komatsu S, Flores S, Gerritsen ME, Anderson DC, Granger DN: Differential up-regulation of circulating soluble and endothelial cell intercellular adhesion molecule-1 in mice. Am J Pathol 1997;151:205-214.
25. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN: Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997;158:1825-1832.
26. Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA, Granger DN: Heterogeneity of expression of E- and P-selectins in vivo. Circ Res 1996;79:560-569.
27. Lush CW, Cepinskas G, Sibbald WJ, Kvietys PR: Endothelial E- and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastrointest Liver Physiol 2001;280:G291-G297.
28. Bauer P, Lush CW, Kvietys PR, Russell JM, Granger DN: Role of endotoxin in the expression of endothelial selectins after cecal ligation and perforation. Am J Physiol Regul Integr Comp Physiol 2000;278:R1140-R1147.
29. Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007;81: 137-143.